XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.25.3

STOCKHOLDERS’ EQUITY | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
STOCKHOLDERS’ EQUITY | STOCKHOLDERS’ EQUITY 2025 Long-Term Incentive Plan — On May 22, 2025, the Company's stockholders approved the EPAM Systems, Inc. 2025 Long Term Incentive Plan (the “2025 Plan”) to be used to issue equity grants to Company personnel. The 2025 Plan is a new plan that replaces the EPAM Systems, Inc. 2015 Long Term Incentive Plan (the “2015 Plan”). The 2025 Plan reserves up to 1,585,970 shares of the Company’s common stock for issuance, plus any shares subject to outstanding awards granted under the 2015 Plan and any predecessor plans that return to the share pool as a result of cancellation or forfeiture. The 2025 Plan will expire 10 years after the effective date and is administered by the Compensation Committee of the Company’s Board of Directors. Stock-Based Compensation The following table summarizes the components of stock-based compensation expense recognized in the Company’s condensed consolidated statements of income for the periods indicated:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Cost of revenues (exclusive of depreciation and amortization) | $ | 21,149 |  |  | $ | 19,576 |  |  | $ | 63,233 |  |  | $ | 58,870 |
Selling, general and administrative expenses | 23,455 |  |  | 22,548 |  |  | 68,385 |  |  | 63,729 |
Total | $ | 44,604 |  |  | $ | 42,124 |  |  | $ | 131,618 |  |  | $ | 122,599 |
Stock Options Stock option activity under the Company’s plans is set forth below:
| Number of Options |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value |  | Weighted Average Remaining Contractual Term (in years)
Options outstanding at January 1, 2025 | 1,206 |  |  | $ | 165.78 |  |  |  |  |
Options exercised | (390) |  |  | $ | 62.64 |  |  |  |  |
Options forfeited | (25) |  |  | $ | 296.29 |  |  |  |  |
Options expired | (14) |  |  | $ | 393.62 |  |  |  |  |
Options outstanding at September 30, 2025 | 777 |  |  | $ | 209.25 |  |  | $ | 14,705 |  |  | 4.3
Options vested and exercisable as of September 30, 2025 | 658 |  |  | $ | 193.91 |  |  | $ | 14,705 |  |  | 3.7
Options expected to vest as of September 30, 2025 | 115 |  |  | $ | 294.30 |  |  | $ | — |  |  | 7.7
As of September 30, 2025, $7.5 million of total remaining unrecognized stock-based compensation cost related to unvested stock options, net of estimated forfeitures, is expected to be recognized over the weighted-average remaining requisite service period of 1.8 years. Restricted Stock Units Service-Based Awards The table below summarizes activity related to the Company’s equity-classified and liability-classified service-based awards for the nine months ended September 30, 2025:
| Equity-Classified Equity-Settled Restricted Stock Units |  | Liability-Classified Cash-Settled Restricted Stock Units
| Number of Shares |  | Weighted Average Grant Date Fair Value Per Share |  | Number of Shares |  | Weighted Average Grant Date Fair Value Per Share
Unvested service-based awards outstanding at January 1, 2025 | 1,212 |  |  | $ | 288.12 |  |  | 89 |  |  | $ | 298.84 |
Awards granted | 838 |  |  | $ | 181.87 |  |  | 52 |  |  | $ | 182.72 |
Awards modified | (2) |  |  | $ | 301.10 |  |  | 2 |  |  | $ | 185.73 |
Awards vested | (376) |  |  | $ | 295.98 |  |  | (36) |  |  | $ | 303.25 |
Awards forfeited/cancelled | (111) |  |  | $ | 241.32 |  |  | (2) |  |  | $ | 267.29 |
Unvested service-based awards outstanding at September 30, 2025 | 1,561 |  |  | $ | 232.50 |  |  | 105 |  |  | $ | 239.07 |
As of September 30, 2025, $248.0 million of total remaining unrecognized stock-based compensation cost related to service-based equity-classified restricted stock units (“RSUs”), net of estimated forfeitures, is expected to be recognized over the weighted-average remaining requisite service period of 2.5 years. As of September 30, 2025, $12.6 million of total remaining unrecognized stock-based compensation cost related to service-based liability-classified cash-settled RSUs, net of estimated forfeitures, is expected to be recognized over the weighted-average remaining requisite service period of 2.5 years. The liability associated with the service-based liability-classified RSUs as of September 30, 2025 and December 31, 2024, was $1.6 million and $4.8 million, respectively, and was classified as Accrued compensation and benefits expenses in the condensed consolidated balance sheets. Performance-Based Awards The table below summarizes activity related to the Company’s performance-based awards for the nine months ended September 30, 2025:
|  |  | Equity-Classified Equity-Settled Restricted Stock Units
|  |  |  |  | Number of Shares |  | Weighted Average Grant Date Fair Value Per Share
Unvested performance-based awards outstanding at January 1, 2025 |  |  |  |  | 62 |  |  | $ | 310.37 |
Awards granted |  |  |  |  | 88 |  |  | $ | 211.02 |
Awards vested |  |  |  |  | (4) |  |  | $ | 488.48 |
Awards forfeited/cancelled |  |  |  |  | (17) |  |  | $ | 262.18 |
Unvested performance-based awards outstanding at September 30, 2025 |  |  |  |  | 129 |  |  | $ | 244.54 |
In addition, as of September 30, 2025, the Company has issued 97 thousand performance-based equity-classified RSUs which are not considered granted for accounting purposes as the future vesting conditions have not yet been determined and these awards are not reflected in the table above. As of September 30, 2025, $15.5 million of total remaining unrecognized stock-based compensation cost related to performance-based equity-classified RSUs is expected to be recognized over the weighted-average remaining requisite service period of 1.8 years. During the three months ended March 31, 2025 and March 31, 2024, the Company granted to its named executive officers and certain other members of senior management performance-based equity-classified RSU awards that vest after 3 years, contingent on meeting certain financial performance targets, market conditions and continued service. The financial performance targets are set by the Compensation Committee of the Board of Directors at the beginning of each year. For the portion of the awards subject to market conditions, fair value was determined using a Monte Carlo valuation model. The portion of the awards associated with financial performance in future years for which the financial performance targets have not yet been determined are not considered granted for accounting purposes. There were 71 thousand such awards as of September 30, 2025. Employee Stock Purchase Plan The 2021 Employee Stock Purchase Plan (“ESPP”) enables eligible employees to purchase shares of EPAM’s common stock at a discount at the end of each designated offering period, which occurs every six months ending April 30th and October 31st. The purchase price is equal to 85% of the fair market value of a share of EPAM’s common stock on the first date of an offering or the date of purchase, whichever is lower. During the nine months ended September 30, 2025, the ESPP participants purchased 107 thousand shares of common stock under the ESPP. During the nine months ended September 30, 2024, the ESPP participants purchased 85 thousand shares of common stock under the ESPP. The Company recognizes compensation expense related to share issuances pursuant to the ESPP on a straight-line basis over the six-month offering period. For the three and nine months ended September 30, 2025, the Company recognized $2.5 million and $7.5 million, respectively, of stock-based compensation expense related to the ESPP. For the three and nine months ended September 30, 2024, the Company recognized $2.3 million and $7.5 million, respectively, of stock-based compensation expense related to the ESPP. As of September 30, 2025, total unrecognized stock-based compensation cost related to the ESPP was $0.9 million, which is expected to be recognized over a period of 0.1 years. Share Repurchases On August 1, 2024, the Board of Directors authorized a share repurchase program (the “2024 Repurchase Program”) for up to $500.0 million of the Company's outstanding common stock. The Company could repurchase shares of its common stock on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The timing and total amount of stock repurchases depended upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. As of September 30, 2025, the Company exhausted the $500.0 million available for purchases of the Company’s common stock under the 2024 Repurchase Program. Prior to the authorization of the 2024 Repurchase Program, the Company repurchased common stock under the 2023 Repurchase Program and exhausted the $500.0 million authorized under that program as of June 30, 2024. During the three and nine months ended September 30, 2025, the Company repurchased 493 thousand and 2,376 thousand shares of its common stock for $82.1 million and $437.0 million, respectively, in cash. During the three and nine months ended September 30, 2024, the Company repurchased 245 thousand and 1,801 thousand shares of its common stock for $50.0 million and $385.0 million, respectively, in cash. All of the repurchased shares have been retired. On October 16, 2025, the Board of Directors authorized a new share repurchase program (the “2025 Repurchase Program”) for up to $1,000.0 million of the Company’s outstanding common stock. The Company may repurchase shares of its common stock on a discretionary basis from time to time through open-market purchases, privately negotiated transactions or other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The timing and total amount of stock repurchases will depend upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The share repurchase program has a term of 24 months, may be suspended or discontinued at any time, and does not obligate the Company to acquire any amount of common stock.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration